Lurasidone

Latuda

Atypical Antipsychotic

NADAC/unit $0.1427

No Shortage Tier 1: 98.8% PA Req: 76.0% 16 Manufacturers 78 ANDAs

Lurasidone treats schizophrenia, bipolar disorder, and related conditions by modulating dopamine and serotonin receptors.

vs. brand Latuda: Generic saves up to 99% per unit

Covered Lives

Market Intelligence

2024-01-31 Class II Recall: SUN PHARMACEUTICAL INDUSTRIES INC

Generic Manufacturers

ACCORD HEALTHCARE INCALEMBIC PHARMACEUTICALS LTDALKEM LABORATORIES LTDANNORA PHARMA PRIVATE LTDAUROBINDO PHARMA LTDCHARTWELL RX SCIENCES LLCDR REDDYS LABORATORIES LTDHERITAGE PHARMA LABS INC DBA AVET PHARMACEUTICALS LABS INCINVAGEN PHARMACEUTICALS INCJUBILANT GENERICS LTDLUPIN LTDMACLEODS PHARMACEUTICALS LTDMSN LABORATORIES PRIVATE LTDSUN PHARMACEUTICAL INDUSTRIES LTDSUNOVION PHARMACEUTICALS INCTORRENT PHARMACEUTICALS LTDZYDUS PHARMACEUTICALS USA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Lurasidone drfinder.aiFind doctors who prescribe Lurasidone rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Lurasidone

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.